CHNS elemental analysis and ICH Q3D elemental impurity testing from an NABL-accredited pharmaceutical laboratory in India.
Elemental analysis encompasses two distinct but complementary capabilities in pharmaceutical testing. CHNS combustion analysis determines the organic elemental composition of drug substances — providing carbon, hydrogen, nitrogen, and sulphur percentages that confirm molecular identity and purity. ICP-based elemental impurity analysis determines trace metal and metalloid levels per ICH Q3D requirements, ensuring pharmaceutical products meet permitted daily exposure limits for all 24 target elements.
Auriga Research operates an NABL-accredited elemental analysis laboratory equipped with high-precision CHNS analysers for combustion-based organic elemental determination and ICP-MS/ICP-OES systems for trace-level inorganic elemental impurity quantification. Our CHNS analyser delivers accuracy within 0.3% absolute for each element, while our ICP-MS provides detection limits in the low parts-per-trillion range — well below the PDE-derived specification limits required by ICH Q3D.
Applications include API identity confirmation and purity assessment by CHNS, ICH Q3D compliance testing for drug substances and drug products, elemental impurity risk assessment for manufacturing process evaluation, and catalyst residue quantification in synthetic API manufacturing.
NABL-accredited CHNS and ICP-MS elemental analysis. ICH Q3D compliance testing with 3-5 day turnaround.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Get Free Guide Request a Quote InsteadNo thanks, I'll keep browsing